Pages that link to "Q70951248"
Jump to navigation
Jump to search
The following pages link to Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Q70951248):
Displaying 50 items.
- Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice (Q26773064) (← links)
- Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease (Q27334826) (← links)
- The toxicity of 6-hydroxydopamine on PC12 and P19 cells (Q28377202) (← links)
- Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β Pathway (Q28390865) (← links)
- Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation (Q28477043) (← links)
- VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity (Q28512294) (← links)
- CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism (Q28579022) (← links)
- Regulation of bat echolocation pulse acoustics by striatal dopamine (Q28740694) (← links)
- Parkinson's disease: mechanisms and models (Q29547424) (← links)
- Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue. (Q30375763) (← links)
- Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury (Q30470435) (← links)
- Mitochondrial toxins in models of neurodegenerative diseases. II: elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment (Q30471062) (← links)
- Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease (Q30493249) (← links)
- MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity (Q30502685) (← links)
- Murine Motor and Behavior Functional Evaluations for Acute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Intoxication (Q30519556) (← links)
- Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease (Q31109638) (← links)
- Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity (Q31992475) (← links)
- Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease (Q33112256) (← links)
- Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons (Q33312931) (← links)
- Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury (Q33563284) (← links)
- Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease (Q33645872) (← links)
- Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model (Q33810589) (← links)
- Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease (Q33835301) (← links)
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease (Q33850971) (← links)
- Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease (Q33872463) (← links)
- Exercise protects against MPTP-induced neurotoxicity in mice. (Q33907587) (← links)
- Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease (Q33943273) (← links)
- Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease (Q33951094) (← links)
- MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons (Q33976952) (← links)
- Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse (Q33987540) (← links)
- Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease (Q34032608) (← links)
- Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration (Q34037199) (← links)
- Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates (Q34061568) (← links)
- Cell death induced by MPTP, a substrate for monoamine oxidase B. (Q34088858) (← links)
- Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice. (Q34389461) (← links)
- Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease (Q34390400) (← links)
- Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. (Q34394747) (← links)
- Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease (Q34476803) (← links)
- RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. (Q34569422) (← links)
- Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration (Q34583071) (← links)
- Protocol for the MPTP mouse model of Parkinson's disease (Q34614573) (← links)
- Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice (Q34760743) (← links)
- Intracellular signalling pathways in dopamine cell death and axonal degeneration. (Q34936423) (← links)
- Environmental factors in Parkinson's disease (Q34995010) (← links)
- A knockout of the caspase 2 gene produces increased resistance of the nigrostriatal dopaminergic pathway to MPTP-induced toxicity (Q35000544) (← links)
- NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease (Q35022998) (← links)
- Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases. (Q35040174) (← links)
- Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders (Q35068792) (← links)
- MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP ) in mouse brain. (Q35069025) (← links)
- Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice (Q35081800) (← links)